FDA wants to limit compounded versions of weight loss drugs

The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.

US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs

By Mariam Sunny April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday proposed excluding Novo Nordisk and ...

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines ​unless they appear ...

Canada Approves Generic GLP-1—Here’s The Difference Between Generic And Compounded Formulas

In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...
Devdiscourse

FDA Targets Compounded Weight-Loss Drugs: Impact on Novo Nordisk and Eli Lilly

The FDA proposes excluding Novo Nordisk and Eli Lilly's weight-loss drugs from active ingredients used by outsourcing ...

FDA moves to exclude weight loss drugs from compounding chemicals list

The FDA has moved to exclude semaglutide, tirzepatide and liraglutide -- which are in several popular weight loss drugs -- ...
Devdiscourse

FDA Proposal Targets Compounded Weight-Loss Drugs

The FDA proposed excluding Novo Nordisk's and Eli Lilly's weight-loss drugs from a key compounding list, potentially ...
AOL

Does compounded Semaglutide work for weight loss?

Does compounded Semaglutide work for weight loss? Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But it’s important to understand ...

FDB Launches Gravimetric Content to Strengthen Safety and Accuracy in IV Medication Compounding

FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise ...